Sign in to view content

Board-Certified Providers Are Associated With a Reduced Risk of Endophthalmitis After Intravitreal Injections

Geoffrey G. Emerson, MD, PhD, FASRS

Video
Published 2021

Related

Quality Assessment of a New Silicone-Free Syringe Developed for Intravitreal Injections
Gustavo Barreto de Melo, MD, PhD, FASRS
On Demand Cases, Courses, and Papers
2021
Episode 23: CANTREAT Study. Ranibizumab Monthly vs Treat-and-Extend for wAMD with Dr. Peter Kertes
Keyvan Koushan, MD, FRCSC
Member Podcasts
2019
Endophthalmitis Rates of Prefilled Ranibizumab Syringes Compared to Conventional Ranibizumab Vials: An International Multicenter Study
Yoshihiro Yonekawa, MD, FASRS
Annual Meeting Talks
2018

Category: Socioeconomics

See more